Lung Cancer
-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
-
Early data suggest air pollution may initiate lung cancer
Researcher Peiyao Wang said early results show that fine particulate matter is causing permanent DNA damage, which could have implications for lung cancer screening.
-
Imaging panel discusses pace, direction of practical AI applications
Amit Gupta, MD, MRMD, CIIP, spoke about the growing application of AI imagery in early-stage lung cancer detection.
-
Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib
Experts said the results of the COMPEL trial support continued treatment with osimertinib beyond progression in this patient population.
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Discussion to examine sublobar resection for early-stage lung cancer
Muhammad S. Ali, MD, MS, FCCP, will chair a Monday afternoon panel session on strategies for early-stage lung cancer in the age of sublobar resection.
-
New data confirms ILD as lung cancer risk factor
Bradford C. Bemiss, MD, and Claudia Henschke, PhD, MD, said the study clearly shows patients with interstitial lung disease have an increased risk of lung cancer.
-
Understanding high-risk factors like PM2.5 in lung cancer
Renelle Myers, MD, FRCPC, discusses factors beyond tobacco use that clinicians should consider when screening for lung cancer, such as pollution exposure.
-
Updates in ninth edition of TNM classification criteria allow for more precise lung cancer staging
Hisao Asamura, MD, said the changes are critical to clinical decision-making in the evolving thoracic oncology treatment landscape.
